BIOSUIS PARVOERY SUSPENSION FOR INJECTION FOR PIGS

Homepage Products Veterinary products BIOSUIS PARVOERY SUSPENSION FOR INJECTION FOR PIGS

Pharmaceutical form

Suspension for injection.

Milky white up to greyish-white liquid. During longer standing the content is divided to limpid liquid and milky white up to greyish sediment.

Composition

Porcine parvovirus, inactivated, strain CAPM V198, S-27                            ≥ 4 log₂ *)

Erysipelothrix rhusiopathiae inactivated, serotype 2, strain 2-64                 RP ≥ 1 **)

*) titre HI antibodies in guinea-pig serum after application of ¼ dose for pigs. Antibodies titre 16 and more must be proved in 4 from 5 guinea-pigs. The resulting value of HI titre is given by mean of titres of antibodies reached in 5 guinea pigs.

**) Relative potency (RP) is given by comparison of antibody level in serum of vaccinated mice with antibody level in mice serum prepared with reference vaccine batch, which complies in challenge test on target animals according to the Phr. Eur. requirements.

Indication

For active immunisation of pigs (gilts, sows) to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae and to prevent transplacental infection of embryos and foetuses of gilts and sows caused by porcine parvovirus.

Onset of immunity:

Porcine parvovirus: 3 weeks after primary vaccination (beginning of pregnancy). 

E. rhusiopathiae: 3 weeks after primary vaccination.

Duration of immunity:

Porcine parvovirus: the vaccination provides the protection of foetuses during the whole pregnancy period.

E. rhusiopathiae: 6 months after primary vaccination. 

Dosage, application and vaccination scheme

The vaccination dose – always 2 ml intramuscularly into the neck muscles behind the ear.

Gilts

Primary vaccination – from 6 months of age 2 vaccination doses in the period of 6 weeks and 3 weeks before mating or insemination. In case of previous vaccination against parvovirus and erysipelas of pigs with monovalent vaccines from Bioveta, a.s. production, if available (administration of 1 vaccination dose against erysipelas from 8 weeks of age and administration of 1 vaccination dose against porcine parvovirus 6 weeks before mating or insemination), one vaccination dose 3 weeks before mating or insemination is sufficient.

Other regular revaccination always with one vaccination dose 3 weeks before each mating or insemination at the latest (but not later than 6 months after previous vaccination).

Sows

Primary vaccination - in case of previous vaccination against parvovirus and erysipelas of pigs with vaccines from Bioveta, a.s. production (see administration schedule for gilts), one vaccination dose 3 weeks before mating or insemination is sufficient.

In case when the sows were not previously vaccinated as gilts (before first farrowing), the primary vaccination same as for gilts should be performed.

Other regular revaccination always with one vaccination dose 3 weeks before each mating or insemination at the latest (but not later than 6 months after previous vaccination).

Storage

Store and transport refrigerated (2 °C – 8 °C).

Protect from frost.

Protect from light.

Withdrawal period

Zero days.

Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 2 years.

Shelf life after first opening the immediate packaging: 10 hours.

Package

10 ml, 50 ml, 100 ml, 250 ml.

Not all pack sizes may be marketed.